| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Section of Hematology/Oncology, Departments of Pediatrics [F. Y., E. V. P.] and Pathology [R. J.], Childrens Hospital of Pittsburgh; The Department of Molecular Genetics and Biochemistry, The University of Pittsburgh Medical Center [E. V. P.]; and the University of Pittsburgh Cancer Institute [E. V. P.], Pittsburgh, Pennsylvania 15213
The CCL6 chemokine gene was identified as a direct positive target of the L-Myc oncoprotein in interleukin 3-dependent 32D myeloid cells. A mutant form of c-Myc, lacking a region of the NH2-terminal domain necessary for transcriptional repression (c-Myc
MBII), also up-regulated CCL6. Chromatin immunoprecipitation showed that L-Myc, c-Myc
MBII, and full-length c-Myc all bound the CCL6 promoter, although the latter was inactive in transcriptional up-regulation. Exogenously added CCL6 induced marked apoptosis in some cell types. However, in 32D cells, the coexpression of c-Myc and CCL6 abrogated interleukin 3 dependence and produced a highly leukemogenic phenotype. In two solid tumor models, CCL6 overexpression also accelerated tumor growth, and/or enhanced local and metastatic spread in association with marked apoptosis of the tumor capsule and adjacent normal tissues. Our results show that CCL6 can be either a positive or negative target for Myc oncoproteins. The chemokine may alter tumor behavior by relieving its growth factor dependency and by promoting invasiveness as a result of local tissue apoptosis.
This article has been cited by other articles:
![]() |
V. de Oliveira-Marques, L. Cyrne, H. S. Marinho, and F. Antunes A Quantitative Study of NF-{kappa}B Activation by H2O2: Relevance in Inflammation and Synergy with TNF-{alpha} J. Immunol., March 15, 2007; 178(6): 3893 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik Deregulation of common genes by c-Myc and its direct target, MT-MC1 PNAS, December 27, 2005; 102(52): 18968 - 18973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |